Enhanced targeted cytotoxic and apoptotic effects of docetaxel by enzyme-mediated controlled release system based on cyclodextrin/maltogenic amylase

This publication has 47 references indexed in Scilit:

• Evolving strategies and application of proteins and peptide therapeutics in cancer treatment
  Biomedicine & Pharmacotherapy, 2023
• Functionalization of β-cyclodextrin with a urea-based PSMA ligand and preliminary studies on targeting prostate cancer cells
  Bioorganic & Medicinal Chemistry Letters, 2022
• Dipeptide inhibitors of the prostate specific membrane antigen (PSMA): A comparison of urea and thiourea derivatives
  Bioorganic & Medicinal Chemistry Letters, 2021
• Comparative effects of β-cyclodextrin, HP-β-cyclodextrin and SBE7-β-cyclodextrin on the solubility and dissolution of docetaxel via inclusion complexation
  Journal of Inclusion Phenomena and Macrocyclic Chemistry, 2020
• Molecular Imprinting of Cyclodextrin Supramolecular Hydrogels Improves Drug Loading and Delivery
  Macromolecular Bioscience, 2018
• Co‐Delivery of Docetaxel and p44/42 MAPK siRNA Using PSMA Antibody‐Conjugated BSA‐PEI Layer‐by‐Layer Nanoparticles for Prostate Cancer Target Therapy
  Macromolecular Bioscience, 2017
• Targeted delivery and pH-responsive release of stereoisomeric anti-cancer drugs using β-cyclodextrin assemblied Fe3O4 nanoparticles
  Applied Surface Science, 2015
• Target-specific delivery of peptide-based probes for PET imaging
  Advanced Drug Delivery Reviews, 2010
• Active targeting schemes for nanoparticle systems in cancer therapeutics
  Advanced Drug Delivery Reviews, 2008
• Is 11 C-choline the most appropriate tracer for prostate cancer?
  European Journal of Nuclear Medicine and Molecular Imaging, 2004